QA: Harrow INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2023_Harrow_INC.pdf

Logs

Graph

Absolute values for 0001360214, Harrow INC

  xvar xval
0 AssetsCurrent 118,260,000
1 IntangibleAssetsNetIncludingGoodwill 24,057,000
2 PropertyPlantAndEquipmentNet 3,486,000
3 remainder_Assets 11,575,000
4 LiabilitiesCurrent 18,632,000
5 LiabilitiesNoncurrent 7,332,000
6 remainder_Liabilities 104,174,000
7 CostOfGoodsAndServicesSold 25,775,134
8 SellingGeneralAndAdministrativeExpense 99,726,057
9 ResearchAndDevelopmentExpense 8,599,679
10 remainder_Expenses 97,063
11 remainder_Revenues 127,388,983
12 remainder_NetIncome -16,699,703
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 157,378,000
1 Liabilities 130,138,000
2 Expenses 134,197,933
3 Revenues 127,388,983
4 StockholdersEquity 27,240,000
5 NetIncome -23,508,653
6 ComprehensiveNetIncome -23,508,653
7 BaseVar 282,901,310
8 EconomicCapitalRatiobeforeLimitedLiability 0.250
9 EconomicCapitalRatio 1.65

Edgar->Model Mapping

Feature Distribution

Change over Time